Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Final AER Guidance Requires Full Address, Recommends Prefatory Language

This article was originally published in The Tan Sheet

Executive Summary

In its final adverse event reports labeling guidance documents released Sept. 1, FDA does not budge on defining "domestic address" as a full mailing address, or on recommending labels include statements directing consumers how to submit AERs
Advertisement

Related Content

McCaskill Not Sold On Retailer Exemption From Supplement AER Filing
Supplement GMP Inspections Reveal Adverse Event Reports, Prompting Warning Letters
GMP Inspectors Will Scrutinize Adverse Event Reporting Compliance
GMP Inspectors Will Scrutinize Adverse Event Reporting Compliance
FDA Says Supplement Adverse Event Under-Reporting Should Feed Growth
Drug, Supplement Industries Need Formal But Timely Guidance - Stakeholders
Drug, Supplement Industries Need Formal But Timely Guidance - Stakeholders
FDA Estimates Dollar Costs For Adverse Event Labeling But Doubts Persist
AER Label Guidance Holds To Requiring Full Addresses For OTCs, Supplements
Return To Sender, Industry Groups Say Of AER Address Guidance
Advertisement
UsernamePublicRestriction

Register

PS103296

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel